Last reviewed · How we verify
NCT04571671: AM
Do müllerian Anomalies Affect Embryo Implantation?
trial testing Collect retrospectively data in Uterine Diseases in 5,000 participants. Completed in 25 July 2019.
25 July 2019
Quick facts
| Lead sponsor | IVI Vigo |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 20 January 2014 |
| Primary completion | 25 July 2019 |
| Estimated completion | 25 July 2019 |
Drugs / interventions tested
- Collect retrospectively data
Conditions studied
- Uterine Diseases — all drugs for Uterine Diseases →
Sponsor
IVI Vigo
Who can join
Adults 35 to 50, female only, with Uterine Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Müllerian anomalies (MA) are associated with infertility and affect approximately 6.3% of the infertile population. The estimation of the frequency of MAs is not without controversy because it depends on the diagnostic method used and sometimes on the established diagnostic criteria. This pathology is associated with abortion during the second trimester in addition to other complications that include preterm labor, fetal malpositions and an increased rate of caesarean section, although some patients may remain asymptomatic. An association between MA and endometriosis has been described and in particular the case of the septum uterus, therefore it is difficult to establish whether the reproductive results of women with MA tdepend only on the uterine factor or also on the quality of the oocytes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Reproductive outcomes of oocyte donation in patients with uterine Müllerian anomalies.
Muñoz E, Fernández I, Pellicer N, Mariani G, et al · · 2023 · cited 2× · PMID 37392783 · DOI 10.1016/j.fertnstert.2023.06.029
Verify or expand the search:
- PubMed search for NCT04571671
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Uterine Diseases
Currently open trials in the same condition.
- NCT07478614 — Multicenter Observational Cohort Study on the Epidemiology of Therapeutic Strategies in Patients Affected by Adenomyosis · recruiting
- NCT04061967 — Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Exam · NA · recruiting
Other IVI Vigo trials
Trials by the same sponsor.
- NCT04734769 — Embryos With Preimplantation Genetic Testing for Aneuploidies (PGT-A) Inconclusive Result: Clinical Implications · unknown
- NCT04549909 — Biochemical Pregnancy Loss. A Multicenter Retrospective Study · completed
- NCT04744519 — hCG Concentration in Peripheral Maternal Blood After Embryo Transfer, Ongoing Pregnancy Rates, and Morphokinetics · completed
- NCT04736160 — Pilot Study: hCG Secreted by Blastocyst as Potential Marker of Embryo Quality · unknown
- NCT04574310 — Does the Air-bubble Location Influence on the Implantation Rate · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04571671 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IVI Vigo
- Last refreshed: 5 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04571671.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing